Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record history now includes a new revision entry v3.5.2 and removes v3.5.0 from the list.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a new 'Study Status' entry on 2026-03-25 and version 9 on 2026-03-23. Deleted the 2025-05-29 entry.SummaryDifference0.4%

- Check32 days agoChange DetectedAdded revision: v3.5.0; removed revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the Record History.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded revision entry v3.4.2 and removed v3.4.1 from the Record History page, updating the displayed site version history.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a new revision entry (v3.4.1) to the record history and removed a funding-status notice along with an older revision (v3.4.0). These are administrative updates to the page's history and do not affect the underlying study data or public-facing trial information.SummaryDifference0.8%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.